• Baicalein: Applied Protocols for Cancer and Inflammation Res

  2026-05-24

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) offers precision inhibition of the 12-LOX pathway, making it indispensable for dissecting apoptosis and inflammation mechanisms. This article delivers actionable workflows, troubleshooting strategies, and a translational perspective on maximizing Baicalein’s research value in cancer biology and metabolic enzyme studies.

• Asunaprevir (BMS-650032): Applied HCV NS3 Protease Inhibitio

  2026-05-23

  Asunaprevir (BMS-650032) stands out for nanomolar potency and broad hepatitis C genotype coverage, enabling advanced workflows in HCV RNA replication inhibition. This article delivers actionable protocol guidance, troubleshooting strategies, and cross-domain insights for researchers leveraging Asunaprevir as an antiviral agent and beyond.

• ATRX Loss Sensitizes Glioma Cells to RTK/PDGFR Inhibitors an

  2026-05-22

  This article highlights how ATRX-deficient high-grade glioma cells exhibit increased vulnerability to receptor tyrosine kinase (RTK) and PDGFR inhibitors, especially when combined with temozolomide. The findings provide a mechanistic rationale for integrating ATRX mutation status into the design and interpretation of chemotherapy resistance studies and clinical trials.

• 7-Ethyl-10-hydroxycamptothecin: Dual-Action SN-38 in Colon C

  2026-05-22

  7-Ethyl-10-hydroxycamptothecin (SN-38) is a highly potent DNA topoisomerase I inhibitor and apoptosis inducer in metastatic colon cancer cell studies. Its dual mechanism—topoisomerase I inhibition and FUBP1 disruption—offers unique value for advanced colon cancer research. The compound’s efficacy, solubility profile, and storage requirements are well-characterized for in vitro applications.

• Streptavidin-FITC: Enhancing LNP Trafficking Studies and Bey

  2026-05-21

  This thought-leadership article explores the mechanistic role and strategic application of Streptavidin-FITC in advanced biotin-streptavidin binding assays, with a focus on intracellular trafficking of lipid nanoparticles (LNPs). Drawing on recent evidence, it offers translational researchers actionable guidance on integrating robust fluorescent detection into workflows that dissect LNP design variables—including the impact of cholesterol on endosomal escape. Competitive insights, detailed protocol parameters, and a visionary outlook position Streptavidin-FITC as an indispensable tool for next-generation nanomedicine research.

• SP600125: Precision JNK Inhibition for Advanced Translation

  2026-05-21

  Explore the multifaceted role of SP600125, a potent JNK inhibitor, in decoding translational regulation, apoptosis, and inflammation. This article delivers mechanistic depth, contextualizes recent chemoproteomic advances, and provides actionable strategic guidance for translational researchers—bridging foundational kinase discovery with next-generation therapeutic innovation.

• Organic Cation Transporter Response to Xenobiotics in Aedes

  2026-05-20

  Kennel and Rouhier (2025) systematically examined how Aedes aegypti mosquitoes excrete synthetic dyes and the role of putative organic cation transporters (OCTs/Ns) in this process. Their findings highlight the limited transcriptional response of these transporters to xenobiotic challenge, underscoring the importance of molecular structure in excretion and mortality, and suggesting novel targets for mosquito control.

• Genomic and Transcriptomic Instability Drives CRC Metastasis

  2026-05-20

  This study systematically links dynamic genomic and transcriptomic changes during colorectal cancer (CRC) metastasis to therapeutic heterogeneity and drug resistance using patient-derived xenograft (PDX) models. The findings underscore how evolving subclonal mutations and gene expression profiles alter response to targeted therapies, with direct implications for oncology research and preclinical drug evaluation.

• Metabolomics Reveals Biomarkers of Carbapenemase Resistance

  2026-05-19

  This article reviews a 2025 study that used LC-MS/MS metabolomics and machine learning to distinguish carbapenemase-producing Enterobacterales (CPE) from non-CPE strains using metabolic signatures. The findings provide a foundation for rapid, mechanism-informed detection of carbapenem resistance and offer new directions for antibiotic resistance and infection research.

• Cathepsin B Inhibitor CA-074: Workflow Best Practices & Cont

  2026-05-19

  Cathepsin B inhibitor CA-074 is a highly selective tool compound for dissecting cathepsin B’s role in cancer metastasis, neurotoxicity, and immune modulation. Researchers use this inhibitor for precise pathway interrogation in vitro and in vivo, guided by well-defined solubility, selectivity, and cytotoxicity profiles. It is not suitable for applications requiring broad-spectrum cysteine protease inhibition or for long-term solution storage.

• Solving Live-Cell Imaging Challenges with Golgi-Tracker Gree

  2026-05-18

  This scenario-driven guide explores how Golgi-Tracker Green (SKU B8813), a BODIPY FL-labeled C5-ceramide probe, delivers robust and reproducible live-cell Golgi imaging for cell viability, proliferation, and cytotoxicity assays. Integrating real laboratory scenarios, we demonstrate its advantages in specificity, workflow reliability, and translational applications relevant to biomedical researchers.

• MDL 28170 Calpain Inhibitor: Optimizing Neuroprotection Assa

  2026-05-18

  MDL 28170, a highly selective calpain inhibitor, empowers researchers to model and mitigate protease-mediated neuronal injury with unmatched precision. Its robust membrane permeability and nanomolar potency unlock new reliability in neuroprotection, apoptosis, and disease models—especially where blood-brain barrier penetration is critical.

• Bifendate (DDB): Applied Protocols for Hepatoprotection Rese

  2026-05-17

  Bifendate (DDB) stands out as a synthetic Schisandrin C derivative with potent hepatoprotective and autophagy-inhibiting capabilities. This guide distills best practices for experimental design, troubleshooting, and advanced in vitro and in vivo applications, drawing on recent mechanistic insights and validated workflows.

• SD 169 (indole-5-carboxamide): Precision in p38 MAPK Inhibit

  2026-05-16

  SD 169 (indole-5-carboxamide) redefines the inhibition of p38 MAPK signaling, offering researchers a dual-action tool for dissecting inflammation, neuroregeneration, and diabetes pathways. Its unique conformational mechanism, validated by cutting-edge structural studies, sets a new benchmark for assay specificity and translational insight.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-15

  This study reveals that naturally occurring angiotensin peptides—including Angiotensin (1-7)—significantly enhance the binding of the SARS-CoV-2 spike protein to the AXL receptor, a mechanism potentially contributing to viral entry in cells with low ACE2 expression. These findings suggest new molecular intersections between the renin–angiotensin system and COVID-19 pathogenesis, with implications for therapeutic target discovery.

450 records 17/30 page Previous Next First page 上5页 1617181920 下5页 Last page